However, patients with Non-small Cell Lung Cancer (NSCLC) who lacked BRG1 production had a worse prognosis than those with normal BRG1 expression, leading to divergent roles of BRG1 as tumor suppressor/promoter in different cancer types [21]. The gene discussed is SMARCA4; the disease is cancer.